Naturally, he was pleasantly surprised when the diabetes drug worked its wonders and helped him lose 50 pounds
As it is not regulated by the FDA, researchers must do their due diligence and look closely at the company's practices and standards
While most back pain during GLP-1-based therapy is likely unrelated to the medication and may resolve with conservative management, certain presentations warrant prompt medical evaluation
Some studies show that adding a GLP-1 agonist to basal insulin results in better blood sugar control with neutral weight effects, or even mild weight loss, compared to intensifying insulin alone
Lin Liao, [email protected] This article was submitted to Thyroid Endocrinology, a section of the journal Frontiers in Endocrinology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers